Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...

A research study with the goal of finding a new treatment for Alzheimer’s disease is moving into Stage 2 of the trial.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

June is Alzheimer’s Awareness Month. Every 65 seconds, someone is diagnosed with Alzheimer’s disease. Right now, nearly 7 ...

In searching for a possible therapeutic target to stop the progress of this disease, an international scientific team, led by ...

Dementia is not a single disease — but rather a syndrome caused by various underlying conditions that damage the brain. The ...

Rosemary is generally safe when used in food amounts, like sprinkled over chicken or in pasta, but rosemary supplements can ...

A major global study tested whether European-derived polygenic risk scores (PGS) for Alzheimer’s disease can predict risk ...

For many years, astrocytes were seen as simple support cells in the brain. Today, that picture is changing fast.

A new study has shed light on how physical activity helps rewire and protect the brain from Alzheimer's disease on a cellular ...

The RESTED-AD Study (Remote Evaluation of Sleep To Enhance Understanding in Early Dementia) investigated the effects of ...

Flies that expressed an Alzheimer’s disease-related protein in their neurons showed signs of accelerated aging.